The EAHP Board, elected for three-year terms, oversees the association’s activities. Comprising directors responsible for core functions, it meets regularly to implement strategic goals. Supported by EAHP staff, the Board controls finances, coordinates congress organization, and ensures compliance with statutes and codes of conduct.
Pharmaceutical care to Pediatric Home Health Care
European Statement
Clinical Pharmacy Services
Why was it done?
Home Health Care is a new emerging model of health care, with a great impact on pediatrics.
Pharmaceutical care is relevant in these population because:
•The pediatric patient,for many reasons, involves difficulties in the use of medications (adaptation of pharmaceutical forms, preparation of magistral formula, off-label use, need for calculations, etc.).
•Health education is esencial to family/primary caregiver of patients admitted at home
What was done?
Reciently a pharmacist has joined to multidisciplinary Home Health Care team.
How was it done?
Pharmaceutical Care consists on:
• Clinical and pharmacotherapeutic daily follow up
• Medication reconciliation for polymedicated patients, with narrow therapeutic range drugs, or chronic diseases (oncological, neurological…)
• Pharmaceutical validation, verifying: the indication, dosage, route of administration, drug interactions, adequacy of the dosage form to the patient’s situation
• Compounding sterile preparations at Pharmacy Service. It allows a longer storage period of them, so it will reduce nursing/medical visits to home in patients with stable health condition, so the unit can admitted more patients
• Active participation in multidisciplinary sessions to advise on pharmacological issues and ensure the maximum efficiency and safety of the treatments
• Dispensing weekly of prescribed medication
• Registration of pharmaceutical interventions and cost saving by compounding sterile preparations
What has been achieved?
The average of pharmaceutical interventions during six months were 17,5 per month, 90.7% were accepted. It means that 57,4% of admited patients to Pediatric Home Health Care Unit were done a pharmaceutical intervention.
The types of pharmaceutical interventions were: 35,3% for dosing of drugs, 27% for pharmacokinetic monitoring, 18% for medication use, 4% by prescription error, 4% for preparation and administration of drugs at home. Others were about monitoring side effects and medication acquisition.
Finally, 657 sterile preparations were compounding at Pharmacy Service, it has involved a cost saving of 5143€.
What next?
It is neccesary an individualized pharmaceutical care to chronic, polymedicated and pluripathological pediatric patient in Home Health Care Unit. It will be performed:
• Clinical and pharmacotherapeutic telematic follow up
• Telephone/telematic assistance with the pharmacist for any doubts about the use of drugs
• A personalized report with individualized recomendations about preparation, administration, manipulation, elimination and acquisition of drugs.